Based on the analysis of the 10 trials, the overall odds ratio was 0.78 (95% confidence interval (CI), 0.69-0.89), indicating that there was a statistically significant decrease in stroke or SE with factor Xa inhibitors compared to warfarin in patients with AF. This evidence concerns the gene F10 and Stroke.